Transactions

Aralez Pharmaceuticals Inc.’s sale of its VIMOVO royalties and Canadian operations to Nuvo Pharmaceuticals Inc. and Nuvo Pharmaceuticals (Ireland)

Date Announced:
08/10/2018

client:
Aralez Pharmaceuticals Inc.

Status:
Closed – 12/31/2018

Value:
$110 million


Download CSV